The effect of superior cervical sympathetic ganglion block using radiofrequency in the treatment of adult patients with tinnitus

Determining the effect of superior cervical sympathetic ganglion block using radiofrequency in the treatment of patients with Tinnitus

This clinical trial has two control and intervention groups, with parallel groups, one-blind, randomized, on 40 patients.

Patients are included in the study based on the entry and exit criteria and after obtaining written consent. They are divided into two groups. the control group, which is treated with Cinnarizine, and the intervention group, which was previously treated with Cinnarizine, but did not respond to the treatment, and will now be treated with Radiofrequency. All patients are subjected to superior cervical sympathetic ganglion block by a specialist doctor in completely sterile conditions. One week, one month, 3, 6, 12, 18 and 24 months (within two years) after the procedure, patients will be examined in person at the clinic. The person evaluating the improvement of tinnitus after treatment will not be aware of the type of treatment performed on the patient, and blinding will be done in a one-way blind. The place of the study is Bo-Ali Sina Medical Education Center, Sari.

Inclusion criteria: People who are over 18 years old Patients with Tinnitus without response to drug treatment Patients who have been examined neurologically and do not have neurological problem Exit criteria: People with known neurological diseases such as MS Patient with coagulation disorders or use of anticoagulants

Intervention group: Patients with Radiofrequency treatment on superior cervical sympathetic ganglion block Control group: Patients treated with cinnarizine drug

Nausea - vomiting / bleeding in the operation area

Patients will be included in the study based on a randomly prepared list. This list contains a series of random numbers, each number is assigned to a type of treatment and according to that treatment is done. 1, 4, 1, Group Ganglion Block 1, 4, 2, Cinnarizine 1, 4, 3, Cinnarizine 1, 4, 4, Group Ganglion Block 2, 4, 1, Group Ganglion Block 2, 4, 2, Cinnarizine 2, 4, 3, Group Ganglion Block 2, 4, 4, Cinnarizine 3, 4, 1, Cinnarizine 3, 4, 2, Group Ganglion Block 3, 4, 3, Group Ganglion Block 3, 4, 4, Cinnarizine 4, 4, 1, Group Ganglion Block 4, 4, 2, Group Ganglion Block 4, 4, 3, Cinnarizine 4, 4, 4, Cinnarizine 5, 4, 1, Cinnarizine 5, 4, 2, Cinnarizine 5, 4, 3, Group Ganglion Block 5, 4, 4, Group Ganglion Block 6, 4, 1, Cinnarizine 6, 4, 2, Group Ganglion Block 6, 4, 3, Cinnarizine 6, 4, 4, Group Ganglion Block 7, 4, 1, Group Ganglion Block 7, 4, 2, Group Ganglion Block 7, 4, 3, Cinnarizine 7, 4, 4, Cinnarizine 8, 4, 1, Cinnarizine 8, 4, 2, Group Ganglion Block 8, 4, 3, Cinnarizine 8, 4, 4, Group Ganglion Block 9, 4, 1, Cinnarizine 9, 4, 2, Group Ganglion Block 9, 4, 3, Cinnarizine 9, 4, 4, Group Ganglion Block 10, 4, 1, Group Ganglion Block 10, 4, 2, Cinnarizine 10, 4, 3, Cinnarizine 10, 4, 4, Group Ganglion Block 11, 4, 1, Cinnarizine 11, 4, 2, Group Ganglion Block 11, 4, 3, Group Ganglion Block 11, 4, 4, Cinnarizine 12, 4, 1, Group Ganglion Block 12, 4, 2, Group Ganglion Block 12, 4, 3, Cinnarizine 12, 4, 4, Cinnarizine 13, 4, 1, Group Ganglion Block 13, 4, 2, Cinnarizine 13, 4, 3, Group Ganglion Block 13, 4, 4, Cinnarizine

The person evaluating the improvement of tinnitus after treatment will not be aware of the type of treatment performed on the patient, and blinding will be done in a single blind.